Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 945-888-9 | CAS number: -
Endpoint summary
Administrative data
Description of key information
The release of ytterbium, zirconium or hafnium from the target substance zirconium oxide, hafnium and ytterbium doped in simulated body fluids indicated that the bio-accessibility is very low for all routes (see section 7.1.1). The hafnium release was below the detection limit, the zirconium release was 0.02 µg/mL and the ytterbium release was 3.24 µg/mL from the target substance within 24 hours in artificial perspiration fluid. Thus, the bioavailability of hafnium, zirconium and/or ytterbium after administration to the skin can expected to be very low. No information was found in the public domain, which would have indicated any skin sensitising properties of hafnium, zirconium and/or ytterbium. Based on the results and in line with the 3R principles, the study is scientifically unjustified.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vitro
- Data waiving:
- study technically not feasible
- Justification for data waiving:
- other:
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
Justification for classification or non-classification
The release of ytterbium, zirconium or hafnium from the target substance zirconium oxide, hafnium and ytterbium doped in simulated body fluids indicated that the bio-accessibility is very low for all routes (see section 7.1.1). The hafnium release was below the detection limit, the zirconium release was 0.02 µg/mL and the ytterbium release was 3.24 µg/mL from the target substance within 24 hours in artificial perspiration fluid. Thus, the bioavailability of hafnium, zirconium and/or ytterbium after administration to the skin can expected to be very low. No information was found in the public domain, which would have indicated any skin sensitising properties of hafnium, zirconium and/or ytterbium. Based on the results and in line with the 3R principles, the study is scientifically unjustified. Based on the low release of test item components to the skin, skin sensitising properties are not expected and therefore no classification is warranted.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
